scholarly journals Guselkumab is superior to fumaric acid esters in patients with moderate‐to‐severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active‐comparator‐controlled phase IIIb trial (POLARIS)

2020 ◽  
Vol 183 (2) ◽  
pp. 265-275 ◽  
Author(s):  
D. Thaçi ◽  
A. Pinter ◽  
M. Sebastian ◽  
C. Termeer ◽  
M. Sticherling ◽  
...  
Keyword(s):  
Fumaric Acid ◽  
Plaque Psoriasis ◽  
Systemic Treatment ◽  
Treatment Results ◽  
Active Comparator ◽  
Severe Plaque Psoriasis ◽  
Fumaric Acid Esters ◽  
Phase Iiib ◽  
Acid Esters

Efficacy and safety of fumaric acid esters in combination with phototherapy in patients with moderate‐to‐severe plaque psoriasis (FAST)

2017 ◽  
Vol 15 (2) ◽  
pp. 180-186 ◽  
Author(s):  
Peter Weisenseel ◽  
Kristian Reich ◽  
Wiebke Griemberg ◽  
Katharina Merten ◽  
Christine Gröschel ◽  
...  
Keyword(s):  
Fumaric Acid ◽  
Plaque Psoriasis ◽  
Efficacy And Safety ◽  
Severe Plaque Psoriasis ◽  
Fumaric Acid Esters ◽  
Acid Esters
Sign in / Sign up

Export Citation Format

Share Document